Karen P. Robards, Director at AtriCure, Inc. (ATRC), bought 10,000 shares at $2.59 ($25K) on 2009-06-03, disclosed to the SEC on 2009-06-03.
Open-market purchase of $25k ATRC by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.50 | 5,000 | $13K | 49.1% |
| 2 | $2.59 | 5,000 | $13K | 50.9% |
| Total | $2.54 avg | 10,000 | $25K | 100% |
| Filing → |
| BSTZ | BUY | 2019-06-27 | $5K | — | Filing → |
| MSO | BUY | 2019-04-18 | $10K | — | Filing → |
| MSO | BUY | 2018-02-26 | $25K | — | Filing → |